Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news



Tate & Lyle miss first-quarter profit target

By Nathan Gray+

Last updated on 25-Jul-2014 at 14:53 GMT2014-07-25T14:53:07Z

Tate& Lyle have delivered below-target results for Q1, but expect to be 'broadly in line' with full year expectations.
Tate& Lyle have delivered below-target results for Q1, but expect to be 'broadly in line' with full year expectations.

Ingredients giant Tate & Lyle has said that group operating profit from Q1 fell below expectation after it was hit by poor weather and exchange rates.

The speciality ingredients supplier said it is optimistic that full-year results will be 'broadly in line' with expectations, despite missing its Q1 target by. The firm said its first quarter operating profit was hit by severe weather in the US this winter, in addition to foreign exchange issues and an unexpected shutdown of its sucralose plant in Singapore.

"The first quarter started slowly in the US following the prolonged and severe winter which caused operational difficulties at the corn plants and led us to enter the current financial year with much lower inventories than usual," said Tate & Lyle in its interim statement. "Although the impact on Bulk Ingredients was less than originally anticipated, it was greater on Speciality Food Ingredients, as we had to balance production to best meet our customers’ needs." 

"Inventories continue to re-build and are expected to return to more normal levels in the current quarter." 

Volume growth?

The firm said that its Speciality Food Ingredients business saw good volume growth in emerging markets, but conceded that overall growth was held back by the US "where, despite firm demand, volumes were only marginally ahead of the comparable period as a result of the supply constraints."

"Sales in Bulk Ingredients in North America were constrained by entering the financial year with much lower inventories in the US than usual following the prolonged and severe winter," it said. "This impacted most product lines, although it was less than originally anticipated, and was also partially mitigated by firmer ethanol margins."

Full year outlook

Tate & Lyle noted that its performance in the first half of the year will be impacted by the supply constraints seen in the first quarter and the temporary Singapore shut down, "while the second half will benefit from the reversal of the Singapore costs."

"Accordingly, Group profits are expected to be weighted to the second half of the financial year," it said.

The firm added that it expects the performance of Speciality Food Ingredients business for the full year to be slightly lower than anticipated.

"However, demand continues to be strong and, notwithstanding current market conditions for sucralose, for the full year Speciality Food Ingredients is expected to deliver volume growth above the wider speciality food ingredients market."

"Overall, the Group’s full year performance, before the impact of exchange rate movements, is expected to be broadly in line with our previous guidance"

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars